86 related articles for article (PubMed ID: 6894288)
1. Thyroid function in patients with Graves' disease long after 131I therapy.
Inoue K; Okamura K; Shiroozu A; Nakashima T; Yoshinari M; Omae T; Nishitani H
Fukuoka Igaku Zasshi; 1980 Jul; 71(7):408-16. PubMed ID: 6894288
[No Abstract] [Full Text] [Related]
2. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
[No Abstract] [Full Text] [Related]
3. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
[TBL] [Abstract][Full Text] [Related]
4. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease (author's transl)].
Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
Nihon Naika Gakkai Zasshi; 1979 Jul; 68(7):724-32. PubMed ID: 113472
[No Abstract] [Full Text] [Related]
6. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
[TBL] [Abstract][Full Text] [Related]
7. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
Guhlmann CA; Rendl J; Börner W
Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
[TBL] [Abstract][Full Text] [Related]
8. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
[TBL] [Abstract][Full Text] [Related]
9. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
10. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
11. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
[TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
[TBL] [Abstract][Full Text] [Related]
13. [Serum free thyroxine after 131I therapy for Graves' disease (author's transl)].
Saito S; Sakurada T; Fukazawa H; Yoshida K; Kaise N; Kitaoka H; Yamamoto M; Kaise K
Kaku Igaku; 1981 Dec; 18(10):1421-4. PubMed ID: 6896222
[No Abstract] [Full Text] [Related]
14. [Thyroid function in thyrotoxicosis patients after radioiodine therapy].
Sivachenko TP; Potsybina VV; Tkachuk LP
Vrach Delo; 1984 Nov; (11):66-9. PubMed ID: 6549362
[No Abstract] [Full Text] [Related]
15. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
16. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
17. Airway complication occurring during radioiodine treatment for Graves' disease.
Kinuya S; Yoneyama T; Michigishi T
Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
[TBL] [Abstract][Full Text] [Related]
18. The role of nuclear medicine in the management of Graves' disease.
Freitas JE
Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
[TBL] [Abstract][Full Text] [Related]
20. A simplified method for treating Graves' disease with radioactive 131I.
Masri MT; Menne M; Rooney BL; Caplan RH
Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
